Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 14, 2023Recruiting
Condition(s):Bladder CancerLast Updated:March 23, 2023Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 26, 2024Not yet recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:January 22, 2024Recruiting
Condition(s):Muscle Invasive Bladder CarcinomaLast Updated:October 10, 2023Recruiting
Condition(s):Muscle Invasive Bladder CarcinomaLast Updated:February 20, 2024Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 14, 2023Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:May 11, 2023Recruiting
Condition(s):Muscle-Invasive Bladder CarcinomaLast Updated:April 6, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.